The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice

Matrix Biology

Volumn 19, Issue 6, 2000, Pages 501-509

  Xie, Wei Fen ^a   Zhang, Xin ^a   Sandell, Linda J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cartilage; Cartilage derived retinoic acid sensitive protein; Mammary buds; Melanoma inhibitory activity; Transgenic mice

Indexed keywords

BETA GALACTOSIDASE; CARTILAGE DERIVED RETINOIC ACID SENSITIVE PROTEIN; MELANOMA GROWTH INHIBITORY FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARTILAGE; CHONDROGENESIS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMAL; CARTILAGE; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE FUSION; HISTOCYTOCHEMISTRY; LAC OPERON; MAMMAE; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA; ESCHERICHIA COLI; MUS MUSCULUS;

EID: 0033790653     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(00)00087-1     Document Type: Article

References (44)

1. SOX9 directly regulates the type-II collagen gene
2. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA
3. Application of lacZ gene fusions to postimplantation development
4. Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIA
5. Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma
6. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
7. Function of MIA in metastasis of malignant melanoma
8. In situ expression patterns of melanoma-inhibiting activity MIA. in malignant melanomas and breast cancers
9. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer
10. Expression of the mouse α1 II. collagen genes is not restricted to cartilage during development
11. Expression of a single transfected cDNA converts fibroblasts to myoblasts
12. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis
13. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation
14. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene
15. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
16. Transgene detection in unpurifed mouse tail DNA by polymerase chain reaction
17. Identification of a phenotype-specific enhancer in the first intron of the rat collagen II gene
18. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism
19. Tissue interaction in androgen response of embryonic mammary rudiment of mouse: identification of target tissue for testosterone
20. SOX9 is a potent activator of the chondrocyte-specific enhancer of the proα1 II. collagen gene
21. A new long form of Sox5 L-Sox5., Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene
22. Toward understanding SOX9 function in chondrocyte differentiation
23. Gene expression changes associated with chemically induced rat mammary carcinogenesis
24. The dopamine β-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice
25. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins
26. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse
27. The human type II procollagen gene: identification of an additional protein-coding domain and location of potential regulatory sequences in the promoter and first intron
28. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide
29. Alternative splice form of type II procollagen mRNA IIA. is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development
30. Mammary embryogenesis
31. Two silencers regulate the tissue-specific expression of the collagen II gene
32. Transcription factor AP-2 essential for cranial closure and craniofacial development
33. Sex reversal by loss of the C-terminal transactivation domain of human SOX9
34. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
35. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display
36. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos
37. Regulation of the mouse cartilage-derived retinoic acid-sensitive protein gene by the transcription factor AP-2
38. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9
39. Developmental pattern of expression of the mouse α1 XI. collagen gene Col11α1
40. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2
41. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis
42. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo